New Delhi, July 4: Alzheimer’s disease is commonly recognized as a memory-related issue. People often associate it with forgetfulness, such as failing to remember names, misplacing items, or struggling to recognize places. However, new research from scientists at Texas A&M Health University has revealed that changes in the brain may begin years before memory loss […]
Leqembi targets beta-amyloid plaques in the brain, aiming to slow Alzheimer’s progression in patients with mild cognitive impairment The Saudi Food and Drug Authority (SFDA) announced today the official approval of Leqembi, the first Alzheimer’s treatment available in Saudi Arabia. This approval marks a significant milestone in addressing Alzheimer’s, a progressive brain disorder that affects […]
BRUSSELS: The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer’s disease, to be sold in the EU under strict conditions.The authorisation was granted Tuesday based on a favourable decision by Europe’s medicines watchdog, which after initial misgivings endorsed the treatment last November for a […]
